Posted On: 08/24/2015 10:51:39 AM
Post# of 72443
Quote:
Last week United Therapeutics Corporation agreed to sell its Priority Review Voucher to AbbVie for $350 Million
- See more at: http://cellceutix.com/cellceutix-requesting-m...AAKXa.dpuf
(0)
(0)Scroll down for more posts ▼
